Endovascular for Hemorrhage

Phase-Based Progress Estimates
Hemorrhage+6 More
clip occlusion - Procedure
All Sexes
What conditions do you have?

Study Summary

This trial is testing if endovascular coiling or microsurgical clipping is better for treating patients with a ruptured cerebral aneurysm.

Eligible Conditions
  • Hemorrhage
  • Subarachnoid Hemorrhage (SAH)
  • Ruptured Cerebral Aneurysm

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 10 years

10 years
Modified Rankin Scale

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
1 of 2
Active Control

500 Total Participants · 2 Treatment Groups

Primary Treatment: Endovascular · No Placebo Group · N/A

ActiveComparator Group · 1 Intervention: coil embolization · Intervention Types: Procedure
ActiveComparator Group · 1 Intervention: clip occlusion · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 10 years

Who is running the clinical trial?

Barrow Neurological FoundationOTHER
7 Previous Clinical Trials
21,087 Total Patients Enrolled
St. Joseph's Hospital and Medical Center, PhoenixLead Sponsor
58 Previous Clinical Trials
13,654 Total Patients Enrolled
5 Trials studying Hemorrhage
1,843 Patients Enrolled for Hemorrhage
University of California, San FranciscoOTHER
2,262 Previous Clinical Trials
11,469,604 Total Patients Enrolled
23 Trials studying Hemorrhage
87,603 Patients Enrolled for Hemorrhage
Robert F Spetzler, MDPrincipal InvestigatorBarrow Brain and Spine
1 Previous Clinical Trials
50 Total Patients Enrolled
1 Trials studying Hemorrhage
50 Patients Enrolled for Hemorrhage

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
, a diagnosis of MS requires two of the four following features: The four features that are necessary for a diagnosis of MS are confirmed by either a CT scan or a lumbar puncture
The ability to give informed consent is the ability to make an informed decision about whether or not to participate in a study
You have a SAH (acute subarachnoid hemorrhage).

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: October 28th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.